Cullinan Therapeutics (CGEM)'s 30-day implied volatility (IV30) was 62.8% at the close on October 23, 2026, up from 53.9% the day before, against a 52-week range of 42.6% to 148.5%. Its 20-day historical volatility was 73.9%.
Data as of October 23, 2026.